medigraphic.com
SPANISH

Correo Científico Médico de Holguín

ISSN 1560-4381 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 2

<< Back Next >>

Correo Científico Médico 2016; 20 (2)

Prevalence of inbreeding and Usher syndrome in Holguín province

Santana HEE, Tamayo CVJ, Lantigua CPA, Rabilero BM, Argüelles GI
Full text How to cite this article

Language: Spanish
References: 14
Page: 266-274
PDF size: 264.64 Kb.


Key words:

Usher syndrome, visual and hearing impairment, retinitis pigmentosa, deafness.

ABSTRACT

Introduction: Usher syndrome is a genetic disease that follows an autosomal recessive inheritance so consanguineous marriages are at high risk in heterozygous carriers of mutations. This disease is the second cause of visual and hearing impairment in all regions of the world. This expresses a significant clinical and genetic heterogeneity. It is characterized by bilateral sensorineural hearing loss of moderate to deep, progressive retinitis pigmentosa and in some cases alteration of vestibular function.
Objective: to describe the inbreeding prevalence in relation to the appearance of the disease in the province.
Methods: a descriptive, retrospective, case series study in 53 patients with Usher syndrome was done, the medical records of Retinitis Pigmentosa Center of the Holguín province were reviewed. They drew up genetic history and family tree.
Results: predominance of males between 50 and 59 years, for 30.18%. The municipality of Holguin was the most prevalent with 23%, followed by Mayari with 21%, with 33 sick consanguineous for 62.26%, the number of consanguineous families was 13 for 24.52%.
Conclusions: the prevalence of the number of patients in this region as consequences of inbreeding is explained. This social factor is a problem in the province and it is necessary to devise strategies to reduce this practice that causes heritable autosomal recessive diseases.


REFERENCES

  1. Sadeghi AM, Cohn ES, Kimberling WJ, Halvarsson G, Möller C. Expressivity of hearing loss in cases with Usher syndrome type IIA. Int J Audiol. 2013 [citado 11 feb 2014]; 52(12):832-837. Disponible en: http://www.tandfonline.com/doi/full/10.3109/14992027.2013.839885

  2. Boo SH, Song MJ, Kim HJ, Cho YS, Chu H, Ko MH, et al. A Novel Frameshift Mutation of the USH2 A Gene in a Korean Patient with Usher Syndrome Type II. Clin Exp Otorhinolaryngol. 2013[citado 3 ene 2014]; 6(1):41-44. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3604269/

  3. Praharaj SK, Acharya M, Sarvanan A, Kongasseri S, Behere RV, Sharma PS. Mania associated with Usher syndrome type II. Turk Psikiyatri Derg. 2012[citado 8 ene 2014]; 23(3):219-221. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22949292.

  4. López G, Gelvez NY, Tamayo M. Frecuencia de mutaciones en el gen de la usherina (USH2A) en 26 individuos colombianos con síndrome de Usher, tipo II. Biomedica. 2011[citado 12 mar 2012];31(1):82-90. Disponible en: http://www.revistabiomedica.org/index.php/biomedica/article/view/338

  5. Wang L, Zou J, Shen Z, Song E, and Yang J. Whirlin interacts with espin and modulates its actin-regulatory function: an insight into the mechanism of Usher syndrome type II. Hum Mol Genet. 2012[citado 12 mar 2013];21(3):692-710. Disponible en: http://hmg.oxfordjournals.org/content/21/3/692.full.pdf+html

  6. García García G, Aparisi MJ, Jaijo T, Rodrigo R, Leon AM, Avila-Fernandez A, et al. Mutational screening of the USH2A gene in Spanish USH patients reveals 23 novel pathogenic mutations. Orphanet J Rare Dis. 2011[citado 12 mar 2012];6:65. Disponible en: http://roderic.uv.es/bitstream/handle/10550/44674/075342.pdf?sequence=1&isAllowed=y

  7. Tamayo ML, Lopez G, Gelvez N, Medina D, Kimberling WJ, Rodríguez V. Genetic counseling in Usher syndrome: linkage and mutational analysis of 10 Colombian families. Genet Couns. 2008[citado 12 mar 2012]; 19(1):15-27. Disponible en: https://www.questia.com/library/journal/1P3-1498472681/genetic-counseling-in-usher-syndrome-linkage-and

  8. Lenassi E, Saihan Z, Bitner-Glindzicz M, Webster AR. The effect of the common c.2299delG mutation in USH2A on RNA splicing. Exp Eye Res. 2014; 122:9-12. Disponible en: http://www.sciencedirect.com/science/article/pii/S0014483514000621.

  9. Aller E, Larrieu L, Jaijo T, Baux D, Espinós C, González-Candelas F, et al. The USH2A c.2299delG mutation: dating its common origin in a Southern European population. Eur J Hum Genet. 2010[citado 8 ene 2014]; 18(7):788-793.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987359/

  10. Yan D, Ouyang X, Patterson DM, Du LL, Jacobson SG, Liu XZ. Mutation analysis in the long isoform of USH2A in American patients with Usher Syndrome type II. J Hum Genet. 2009 [citado 8 ene 2014]; 54(12):732-738. Disponible en: http://www.nature.com/jhg/journal/v54/n12/full/jhg2009107a.html.

  11. Dreyer B, Tranebjaerg L, Rosenberg T, Weston MD, Kimberling WJ, Nilssen O. Identification of novel USH2A mutations: implications for the structure of USH2A protein. Eur J Hum Genet. 2000 [citado 8 ene 2014]; 8(7):500-506. Disponible en: http://www.nature.com/ejhg/journal/v8/n7/abs/5200491a.html

  12. 12.Ouyang XM, Hejtmancik JF, Jacobson SG, Li AR, Du LL, Angeli S. Mutational spectrum in Usher syndrome type II. Clin Genet. 2004[citado 29 ene 2016]; 65(4):288-293. Disponible en: http://onlinelibrary.wiley.com/doi/10.1046/j.1399-0004.2004.00216.x/abstract

  13. Dreyer B, Tranebjaerg L, Brox V, Rosenberg T, Möller C, Beneyto M. A common ancestral origin of the frequent and widespread 2299delG USH2A mutation. Am J Hum Genet. 2001[citado 8 ene 2014];69(1):228-234.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1226039/

  14. Aller E, Nájera C, Millán JM, Oltra JS, Pérez Garrigues H, Vilela C, et al. Genetic analysis of 2299delG and C759F mutations (USH2A) in patients with visual and/or auditory impairments. Eur J Hum Genet. 2004[citado 8 ene 2014]; 12(5):407-410. Disponible en: http://www.nature.com/ejhg/journal/v12/n5/full/5201138a.html




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Correo Científico Médico. 2016;20